OCUPHIRE PHARMA INC. - COMMON STOCK
1.5800
21-يونيو-24 15:59:52
15 متأخرة بدقائق
الأسهم
-0.0200
-1.25%
نطاق اليوم
1.5450 - 1.6450
ISIN
N/A
المصدر
NASDAQ
-
01 نوفمبر 2023 08:05:00 بحسب Nasdaq GlobeNewswire
-
Ocuphire Pharma to Present at AAO 2023 and Eyecelerator Retina Showcase
26 أكتوبر 2023 08:00:01 بحسب Nasdaq GlobeNewswire
-
Ocuphire Pharma to Present at Euretina and Retina Society Conferences in October
06 أكتوبر 2023 08:00:00 بحسب Nasdaq GlobeNewswire
-
27 سبتمبر 2023 08:00:12 بحسب Nasdaq GlobeNewswire
-
Ocuphire Pharma to Participate in Three Upcoming Investment Bank Conferences
11 سبتمبر 2023 09:41:55 بحسب Nasdaq GlobeNewswire
-
Ocuphire Pharma to Present at ESCRS 2023 and MODLive! Conferences in September
07 سبتمبر 2023 09:00:00 بحسب Nasdaq GlobeNewswire
-
Abstract on ZETA-1 Study of APX3330 Receives Award at Women in Ophthalmology (WIO) Summer Symposium
28 أغسطس 2023 08:00:00 بحسب Nasdaq GlobeNewswire
-
Ocuphire Pharma Announces Financial Results for Second Quarter 2023 and Provides Corporate Update
11 أغسطس 2023 08:00:00 بحسب Nasdaq GlobeNewswire
-
08 أغسطس 2023 08:00:01 بحسب Nasdaq GlobeNewswire
-
26 يوليو 2023 08:00:01 بحسب Nasdaq GlobeNewswire
-
Ocuphire Pharma, Inc. Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)
10 يوليو 2023 17:19:14 بحسب Nasdaq GlobeNewswire
-
27 يونيو 2023 08:00:01 بحسب Nasdaq GlobeNewswire
-
21 يونيو 2023 08:00:00 بحسب Nasdaq GlobeNewswire
-
Ocuphire Presents APX3330 ZETA-1 Data at Clinical Trials at the Summit (CTS) 2023
12 يونيو 2023 08:00:01 بحسب Nasdaq GlobeNewswire
-
Ocuphire Pharma, Inc. Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)
24 مايو 2023 16:05:00 بحسب Nasdaq GlobeNewswire
-
Ocuphire Pharma Announces Financial Results for First Quarter 2023 and Provides Corporate Update
15 مايو 2023 08:00:01 بحسب Nasdaq GlobeNewswire
-
Ocuphire Announces APX3330 and Nyxol® Data Presentations at ASCRS 2023 and Eyecelerator
02 مايو 2023 08:30:00 بحسب Nasdaq GlobeNewswire
-
Ocuphire Provides Corporate Update and Reiterates Previous Guidance on Clinical Programs
25 أبريل 2023 08:00:01 بحسب Nasdaq GlobeNewswire
-
Ocuphire Appoints Rick Rodgers as Interim Chief Executive Officer
21 أبريل 2023 08:00:00 بحسب Nasdaq GlobeNewswire
-
30 مارس 2023 08:00:00 بحسب Nasdaq GlobeNewswire